semaglutide phase 2 2·4 mg once a week in adults with overweight or obesity, and type diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, 3 trial cagrilintide + semaglutide dosage chart

Berberine has shown promise in some trials for improving glycaemic control in type 2 diabetes, with mechanisms possibly involving improved insulin sensitivity and altered gut microbiota

9 Studies with follow-up of more than 1 year At longer follow-up periods, no significant differences were found between the PRP group and non-PRP group on Lysholm score, Ikeuchi grade, and Visual Analog Scale (VAS) for pain at the last follow-up, as reported by numerous studies

Indication context: Semaglutide injection is FDA-approved under brand names Ozempic (type 2 diabetes, CV risk reduction) and Wegovy (chronic weight management, obesity or overweight with 1 weight-related comorbidity)

This could indicate a serious condition requiring medical intervention